1. Home
  2. BIRK vs RGEN Comparison

BIRK vs RGEN Comparison

Compare BIRK & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIRK
  • RGEN
  • Stock Information
  • Founded
  • BIRK 1774
  • RGEN 1981
  • Country
  • BIRK United Kingdom
  • RGEN United States
  • Employees
  • BIRK N/A
  • RGEN N/A
  • Industry
  • BIRK
  • RGEN Medical/Dental Instruments
  • Sector
  • BIRK
  • RGEN Health Care
  • Exchange
  • BIRK Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • BIRK 10.1B
  • RGEN 7.1B
  • IPO Year
  • BIRK 2023
  • RGEN N/A
  • Fundamental
  • Price
  • BIRK $46.29
  • RGEN $128.50
  • Analyst Decision
  • BIRK Strong Buy
  • RGEN Buy
  • Analyst Count
  • BIRK 14
  • RGEN 12
  • Target Price
  • BIRK $67.71
  • RGEN $177.78
  • AVG Volume (30 Days)
  • BIRK 1.7M
  • RGEN 756.1K
  • Earning Date
  • BIRK 02-20-2025
  • RGEN 04-30-2025
  • Dividend Yield
  • BIRK N/A
  • RGEN N/A
  • EPS Growth
  • BIRK 179.66
  • RGEN N/A
  • EPS
  • BIRK 1.21
  • RGEN N/A
  • Revenue
  • BIRK $1,929,273,217.00
  • RGEN $634,439,000.00
  • Revenue This Year
  • BIRK $20.85
  • RGEN $12.24
  • Revenue Next Year
  • BIRK $17.06
  • RGEN $15.24
  • P/E Ratio
  • BIRK $38.12
  • RGEN N/A
  • Revenue Growth
  • BIRK 20.51
  • RGEN 0.33
  • 52 Week Low
  • BIRK $41.00
  • RGEN $113.50
  • 52 Week High
  • BIRK $64.78
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • BIRK 44.64
  • RGEN 34.73
  • Support Level
  • BIRK $44.44
  • RGEN $135.71
  • Resistance Level
  • BIRK $47.88
  • RGEN $147.00
  • Average True Range (ATR)
  • BIRK 1.87
  • RGEN 6.09
  • MACD
  • BIRK 0.49
  • RGEN -1.57
  • Stochastic Oscillator
  • BIRK 72.01
  • RGEN 12.43

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: